Coexpression of cyclin A and β‐catenin and survival in breast cancer patients

I. Bukholm,G. Bukholm,J. Nesland

DOI: https://doi.org/10.1002/ijc.1432

2001-10-01

International Journal of Cancer

Abstract:b-cateni n performs dual functions in the cell. It has acrucial role in cell-cel adhesion as well as a signalling role as a member of the WNt/wg pathway. 2,3 It is now clear that b-catenin is localised in 2 cellular pools, which correspond to these 2 functions. 4,5 One comprises b-cateni n as part of large molecular weight complexes involved in E-cadherin-mediate d cell adhesion, while the second, mediating signalling, is associated with monomeri c b-catenin. 4–6 It is likely that the role of b-cateni n in tumorigenesi s arises as a consequenc e of the deregulation of the signalling properties of b-cateni n and abnormal activation of downstream transcriptional targets. Lin et al.7 have recentl y demonstrate d that cytoplasmic expression of b-cateni n is an independen t prognosti c factor in patient s with primary breast carcinoma. Although there are several known transcriptional target s of the Wnt/wg pathway during development , identification of the target s relevant to human tumorigenesi s has been difficult. Recently, cMYC and cyclin D1 were identified as TCF/bcateni n transcriptional target s in colon cancer. 8,9 Since cyclin D1 protein overexpressio n is often detected without a corresponding amplification of the gene, we wanted to evaluat e if therewasany association between overexpressio n of cyclin D1 and abnormal expression of the b-cateni n protein in human invasive breast carcinomas . We have in a recent study shown that cyclin A is a highly significant prognosti c factor for breast cancer patients. We therefore wanted to examine the significance of b-cateni n for prognosi s in amultivariate model where the cyclins A, D1, D3 and E were included.